The presence of TILs, particularly CD8+ T cells and tumor-infiltrating natural killer (NK) cells, correlate with an enhanced pathological complete response (PCR), a reduced risk of recurrence, and better survival in TNBC patients [32,33]. This evidence concerns the gene CD8A and neoplasm.